ArticleInvestigational new drugs2013

The prostate cancer blocking potential of the histone deacetylase inhibitor LBH589 is not enhanced by the multi receptor tyrosine kinase inhibitor TKI258.

Stefan Vallo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.